431
Participants
Start Date
March 31, 2002
Primary Completion Date
November 30, 2002
Study Completion Date
November 30, 2002
Tramadol HCl Contramid® Once A Day
The patients orally self-administered the study medication: either 100, 200, 300 or 400 mg Tramadol HCl Contramid® Once A Day. Each patient was titrated to his or her optimum dose (up to a maximum of 400 mg) during the Titration Phase, which lasted between 4 and 12 days. The optimum dose was taken throughout the study.
Tramadol HCl Twice a day
The patients orally self-administered the study medication: either 200, 300 or 400 mg Tramadol HCl Twice a day. Each patient was titrated to his or her optimum dose (up to a maximum of 400 mg) during the Titration Phase, which lasted between 4 and 12 days. The optimum dose was taken throughout the study.
Lead Sponsor
Labopharm Inc.
INDUSTRY